Aktieanalys

BioInvent Q3 2022: financial position strengthened, projects progressing - Redeye

{newsItem.title}

Redeye Publicerad: 28 Oct 2022 09:32

Redeye comments on BioInvents report for the third quarter, which saw a further strengthening of the financial position and progress in the clinical development programs.

Länk till analysen i sin helhet: https://www.redeye.se/research/860181/bioinvent-q3-2022-financial-position-strengthened-projects-progressing?utm_source=finwire&utm_medium=RSS

Nyheter om Bioinvent

Läses av andra just nu

Om aktien Bioinvent

Senaste nytt